Clinical Trial Design Considerations in the Era of Targeted Therapy

被引:0
|
作者
Sridhara, Rajeshwari [1 ]
机构
[1] US FDA, Rockville, MD 20857 USA
关键词
D O I
10.1093/annonc/mdz308.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PSY1 - 2
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [41] Metastatic bone disease in the era of bone-targeted therapy: clinical impact
    Ibrahim, Toni
    Farolfi, Alberto
    Mercatali, Laura
    Ricci, Marianna
    Amadori, Dino
    TUMORI JOURNAL, 2013, 99 (01): : 1 - 9
  • [42] Current Statistical Challenges in Oncology Clinical Trials in the Era of Targeted Therapy Comment
    Ivanova, Anastasia
    Anderson, Keaven M.
    Rosner, Gary L.
    Rubin, Eric
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (04): : 357 - 358
  • [43] HowImaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy
    Farwell, Michael D.
    Clark, Amy S.
    Mankoff, David A.
    JAMA ONCOLOGY, 2015, 1 (04) : 421 - 422
  • [44] Targeted Therapy for Cancer in the Genomic Era
    Afghahi, Anosheh
    Sledge, George W., Jr.
    CANCER JOURNAL, 2015, 21 (04): : 294 - 298
  • [45] Targeted antimicrobial therapy in the microbiome era
    Stone, V. N.
    Xu, P.
    MOLECULAR ORAL MICROBIOLOGY, 2017, 32 (06) : 446 - 454
  • [46] Rechallenge of drugs in the era of targeted therapy
    Nishida, Toshirou
    Doi, Toshihiko
    LANCET ONCOLOGY, 2013, 14 (12): : 1143 - 1145
  • [47] The targeted therapy era of breast cancer
    Osborne, C. Kent
    Harrison, Natalie
    BREAST CANCER MANAGEMENT, 2012, 1 (02) : 123 - 126
  • [48] Genetics in the era of targeted CLL therapy
    Stankovic, Tatjana
    Kwok, Marwan
    BLOOD, 2020, 135 (26) : 2333 - 2334
  • [49] Drug development in the targeted therapy era
    Paoletti, Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3815 - 3816
  • [50] Role of anthracyclines in the era of targeted therapy
    Cortes-Funes, Hernan
    Coronado, Cyntia
    CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) : 56 - 60